| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/12/2008 | EP1768602A4 Combination drug therapy for reducing scar tissue formation |
| 03/12/2008 | EP1705182A4 Antitumoral and antiviral peptides |
| 03/12/2008 | EP1668031B1 Homogeneous preparations of il-29 |
| 03/12/2008 | EP1594896B1 Modified soluble t cell receptor |
| 03/12/2008 | EP1567551A4 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis |
| 03/12/2008 | EP1506317B1 Marker molecules associated with lung tumors |
| 03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
| 03/12/2008 | EP1434590B1 Method for inhibiting the formation of seromas using factor xiii |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1292611B1 Glycopeptide carboxy-saccharide derivatives |
| 03/12/2008 | EP1238065B1 Factor x analog with an improved ability to be actived |
| 03/12/2008 | EP1225184B1 Human antithrombin variants |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP1178803B1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/12/2008 | EP1037657B1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 03/12/2008 | EP0973538B1 Modified proteins which bind extracellular matrix components |
| 03/12/2008 | EP0972048B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0833659B1 Therapeutic fragments of von willebrand factor |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142233A Agents inhibiting the cathelin-like protein hcap18/ll-17 |
| 03/12/2008 | CN101142232A KUNITZ-type recombinant inhibitor |
| 03/12/2008 | CN101142229A Htm4 used for cell-cycle regulation through its interaction with kap |
| 03/12/2008 | CN101142228A Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
| 03/12/2008 | CN101141977A Use of the Mst protein for the treatment of a thromboembolic disorder |
| 03/12/2008 | CN101141976A Local treatment of bone defects with matrix releasing bmp or pth |
| 03/12/2008 | CN101141975A Vegf拮抗剂制剂 Vegf antagonist preparations |
| 03/12/2008 | CN101141974A Protein introducing carrier, protein introducing agent given by using the carrier, method for introducing the protein, protein introduced cell, and method for producing the cell |
| 03/12/2008 | CN101140274A Insulinogen C peptide biological activity measuring method |
| 03/12/2008 | CN101139625A Ace inhibitory peptides from plant materials |
| 03/12/2008 | CN101139613A Antineoplastic dibasic polypeptide and application and preparation method thereof |
| 03/12/2008 | CN101139592A Sequence and preparation method for novel signal conus O-superfamily toxin and uses thereof |
| 03/12/2008 | CN101139590A Hybrid expression of neisserial proteins |
| 03/12/2008 | CN101139581A Mutational SHV beta-lactamase, gene order and uses thereof |
| 03/12/2008 | CN101139578A Double-functional staphylokinase mutant having platelet aggregation resistance and fibrinolytic activity, application and preparation method thereof |
| 03/12/2008 | CN101139569A alpha-amylase inhibitor production bacterium and method for preparing alpha-amylase inhibitor and application |
| 03/12/2008 | CN101139399A Fused protein restructuring target lethal leukemia cells and preparation method and use thereof |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139390A Pig gamma interferon and encoding genes and use thereof |
| 03/12/2008 | CN101139384A 5-peptide derivative, preparation method and use thereof |
| 03/12/2008 | CN101138632A Compound stypticum |
| 03/12/2008 | CN101138631A Novel recombinant parathyroid hormone (1-34) correlated peptide nose drops |
| 03/12/2008 | CN101138630A Fibrin glue composition for repairing nerve damage and methods thereof |
| 03/12/2008 | CN101138629A Recombinant human keratinocyte growth factor-2 freeze dried agent |
| 03/12/2008 | CN101138572A Medicament for treating children lax |
| 03/12/2008 | CN100374894C 凸轮环 Cam ring |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374559C Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application |
| 03/12/2008 | CN100374462C Gerobriecin pancrease glucagon peptidel (SGLP-1), its preparation and use |
| 03/12/2008 | CN100374461C Glucagon-like peptide-2 and its therapeutic use |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374159C Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
| 03/12/2008 | CN100374158C application of agent for lowering the cell ATP level in preparing medicine |
| 03/12/2008 | CN100374157C Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 03/12/2008 | CN100374156C Health products for face care and body care |
| 03/12/2008 | CN100374155C Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals |
| 03/12/2008 | CN100374154C Sincalide formulations |
| 03/12/2008 | CN100374153C Use of GLP-1 or analogs in treatment of myocardial infraction |
| 03/12/2008 | CN100374152C Hypersensitivity reaction inhibitor |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
| 03/12/2008 | CN100374085C Method and apparatus for production of a skin graft and the graft produced thereby |
| 03/12/2008 | CN100374044C Primary composition containing lipophilic bioactive compound |
| 03/11/2008 | US7342109 Used in diagnosis; small cell lung cancer, lung adenocarcinoma, T-cell lymophoblastic lymphoma, glioblastoma, gastric carcinoma, colon adenocarcinoma, prostate carcinoma, pancreatic carcinoma, esophagus epidermoid carcinoma and promonocytic leukemia |
| 03/11/2008 | US7342108 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof |
| 03/11/2008 | US7342101 Immunization against Coccidioides spp. fungi, protein and peptide antigens |
| 03/11/2008 | US7342097 PRO1309 polypeptides |
| 03/11/2008 | US7342096 PRO1879 polypeptide |
| 03/11/2008 | US7342095 Peptidomimetic inhibitors of STAT activity and uses thereof |
| 03/11/2008 | US7342094 Tumor vaccines for MUC1-positive carcinomas |
| 03/11/2008 | US7342093 nhibitor of Apoptosis (IAP) proteins, cancer |
| 03/11/2008 | US7342092 Vaccines as dosage forms; acute myeloblastic leukemia |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence |
| 03/11/2008 | US7342089 Cyclic peptides for treatment for cachexia |
| 03/11/2008 | US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome |
| 03/11/2008 | US7342028 Medical use for tachykinin antagonists |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341999 Povidone-containing carriers for polypeptide growth factors |
| 03/11/2008 | US7341998 Conus californicus neurotoxins |
| 03/11/2008 | US7341997 EPH gene expression inhibition to facilitating tissue repair arising from disease or injuries |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | US7341994 to structurally mimic GD3, which are known as tumor associated antigens found in tumors such as melanoma; vaccine; i.e., a carcinostatic effect and an inhibitory effect for cancerous metastasis |
| 03/11/2008 | US7341993 Cross-linked glycopeptide—cephalosporin antibiotics |
| 03/11/2008 | US7341992 Fusion protein comprising lectin domain of thrombomodulin for use in treatment of treatment and prevention of inflammation associated with ischemic perfusion injury |
| 03/11/2008 | US7341991 Inhibitors of amyloid precursor protein processing |
| 03/11/2008 | US7341989 Administration of a comparatively short regimen of luteinizing hormone (LH) starting at the beginning of the stimulatory phase, and followed by follicle stimulating hormone (FSH) administration in a controlled ovarian hyperstimulation (COH) treatment to enhance multiple folliculogenesis |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341869 Compositions and methods for treating diabetes |
| 03/11/2008 | US7341866 Gene expression patterns; diagnosis, therapy disease |
| 03/11/2008 | US7341849 Expression vector comprising nucleotide sequences coding serum response element receptor (SERB-2) for use in identifying modulator for prevention and treatment of nervous system disorders |
| 03/11/2008 | US7341843 Analyzing antibodies/fragments thereof via enzyme-linked immunosorbent assay or radioimmunoassay, for diagnosis and therapy; vaccines |
| 03/11/2008 | US7341740 Human mitochondrial proteins and polynucleotide encoding the proteins |
| 03/11/2008 | US7341739 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 03/11/2008 | US7341733 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient |
| 03/11/2008 | US7341732 Methods for treating mastitis in a milk producing animal |